Financial News

Aveo Pharmaceuticals (NQ: AVEO )

8.580 USD +0.030 (+0.35%)

Official Closing Price Updated: 4:39 PM EST, Jan 20, 2021 Add to My Watchlist

Price and Volume

Volume	653,214
Open	8.550
Bid (Size)	8.500 (2)
Ask (Size)	8.640 (1)
Prev. Close	8.550
Today's Range	7.950 - 8.780
52wk Range	0.4653 - 10.71
Shares Outstanding	118,867,471
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

AVEO Oncology Announces Commitment for an Incremental $10 Million Loan in Addition to Current Tranched, $35 Million Debt Facility with Hercules Capital

Today 7:00 EST

AVEO Oncology (Nasdaq: AVEO) today announced that it has received a commitment letter for an incremental $10 million loan from Hercules Capital, Inc. (NYSE: HTGC, “Hercules”) and its affiliates, to be...

AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA®) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma

January 15, 2021

AVEO Oncology (Nasdaq: AVEO) today announced the presentation of results from the Phase 1b portion of the Phase 1b/2 DEDUCTIVE clinical trial of tivozanib (FOTIVDA®), AVEO’s vascular endothelial growth...

Performance

YTD	+43.72%	+43.72%
1 Month	+55.43%	+55.43%
3 Month	+52.13%	+52.13%
6 Month	+83.73%	+83.73%
1 Year	+1288.35%	+1288.35%

More News

AVEO Oncology Highlights Recent Progress and 2021 Outlook

January 07, 2021

AVEO Oncology Announces Participation at Two Upcoming Investor Conferences

January 06, 2021

AVEO Oncology Announces Webcast of Presentation at the 39th Annual J.P. Morgan Healthcare Conference

January 05, 2021

AVEO Oncology to Present at the Stifel 2020 Virtual Healthcare Conference

November 10, 2020

AVEO Oncology Reports Third Quarter 2020 Financial Results and Provides Business Update

November 09, 2020

AVEO Oncology and EUSA Pharma Announce Annals of Oncology Publication of Data from Phase 1b/2 TiNivo Study in Renal Cell Carcinoma

November 05, 2020

AVEO Oncology Announces Appointment of David W. Crist as Vice President of Sales

October 19, 2020

12 Health Care Stocks Moving In Tuesday's After-Market Session

January 12, 2021

The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off

January 09, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Aveo Pharmaceuticals (NQ: AVEO )

Price and Volume

Top News

Performance

More News

Popular Pages